Search

Your search keyword '"Eldere, J"' showing total 470 results

Search Constraints

Start Over You searched for: Author "Eldere, J" Remove constraint Author: "Eldere, J"
470 results on '"Eldere, J"'

Search Results

151. Bile acids in peroxisomal disorders

152. Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophy

153. Effect of isoprenaline on intracellular Ca uptake and on Ca influx in arterial smooth muscle.

154. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests

162. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)

163. Direct identification of bacteria in clinical respiratory samples using fluorescent amplicon length analysis of 16S–23S rRNA spacer-region

164. Report of working group 2: Healthcare needs in the organisation and management of infection.

165. Quinolones in 2005: an update.

166. Viability of cultured periodontal pocket epithelium cells and Porphyromonas gingivalis association.

167. Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.

168. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.

169. Viral aetiology of influenza-like illness in Belgium during the influenza A(H1N1)2009 pandemic.

170. Killing of anaerobic pathogens by predatory bacteria.

171. Interference with Aggregatibacter actinomycetemcomitans: colonization of epithelial cells under hydrodynamic conditions.

172. Colonization of hard and soft surfaces by Aggregatibacter actinomycetemcomitans under hydrodynamic conditions.

173. Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

174. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

175. Polyclonal Staphylococcus epidermidis intravascular catheter-related infections.

176. Disruption of nasopharyngeal epithelium by pneumococci is density-linked.

177. Reliability of the ica ,aap andatlE genes in the discrimination between invasive, colonizing and contaminantStaphylococcus epidermidis isolates in the diagnosis of catheter-related infections.

178. Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium—update (1994–98).

179. Effect of supervised implementation of the international classification of functioning, disability and health on physiotherapeutic electronic patient records: A randomized controlled trial.

180. Exploiting the aggregation propensity of beta-lactamases to design inhibitors that induce enzyme misfolding.

181. Cervicofacial actinomycosis following third molar removal: case-series and review.

182. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.

183. Supervised teaching and feedback improve physiotherapists' reporting of the International Classification of Functioning, Disability and Health in physiotherapeutic electronic patient records: A proof-of-concept randomized controlled trial.

184. Translating Data From an Electronic Prescribing and Medicines Administration System Into Knowledge: Application to Doctor-Nurse Time Discrepancy in Antibiotic Ordering and Administration.

185. Compliance with evidence-based guidelines for the prevention of central line-associated bloodstream infections in a Belgian home care setting: An observational study.

186. Synthesis of conjugated PIA-rSesC and immunological evaluation against biofilm-forming Staphylococcus epidermidis.

187. Outpatient parenteral antimicrobial therapy and antibiotic stewardship: opponents or teammates?

188. Frequency and Pattern of IgE-mediated Sensitization to Aero and Food Allergens in Ahvaz, Province of Khuzestan in Southwestern Iran.

189. Ses proteins as possible targets for vaccine development against Staphylococcus epidermidis infections.

190. Aggregating sequences that occur in many proteins constitute weak spots of bacterial proteostasis.

191. Validation of the Child HCAHPS survey to measure pediatric inpatient experience of care in Flanders.

192. De novo design of a biologically active amyloid.

193. sesC as a genetic marker for easy identification of Staphylococcus epidermidis from other isolates.

194. Protein aggregation as an antibiotic design strategy.

195. The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation.

196. Performance of strip-based glucose meters and cassette-based blood gas analyzer for monitoring glucose levels in a surgical intensive care setting.

197. Novel LC-MS/MS method for plasma vancomycin: comparison with immunoassays and clinical impact.

198. Selectivity of aggregation-determining interactions.

199. Non-typeable Haemophilus influenzae, an under-recognised pathogen.

Catalog

Books, media, physical & digital resources